CLOVIS ONCOLOGY INC (CLVS) Stock Cash Flow
NASDAQ:CLVS - Nasdaq - US1894641000 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -251.91M | -264.52M | -369.21M | -400.42M | -368.01M | |||
| Depreciation Amortization | 7.71M | 8.50M | 8.20M | 7.77M | 4.60M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | 29.56M | 30.27M | 11.96M | 8.33M | -55.20M | |||
| Interest Paid | 10.20M | 11.07M | 12.08M | 10.52M | 9.19M | |||
| Other non cash items | 39.06M | 29.70M | 96.33M | 60.71M | 52.61M | |||
| OPERATING CASH FLOW | -175.57M | -196.06M | -252.73M | -323.62M | -366.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -266.00K | -312.00K | -8.35M | -19.04M | -64.24M | |||
| Other Investing Activity | N/A | 0.00 | 134.68M | 162.44M | -200.00M | |||
| INVESTING CASH FLOW | -266.00K | -312.00K | 126.33M | 143.40M | -264.24M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 33.89M | -17.74M | -44.18M | 116.78M | 290.64M | |||
| Stock Issued/Repurchased | 32.45M | 118.11M | 248.03M | 3.27M | 97.86M | |||
| Other Financing Activity | 0.00 | -213.00K | -210.00K | -160.00K | -40.00K | |||
| FINANCING CASH FLOW | 66.35M | 100.16M | 203.64M | 119.89M | 388.46M | |||
| Exchange Rate Effect | -4.13M | -589.00K | 1.15M | 290.00K | -550.00K | |||
| CHANGE IN CASH | -113.63M | -96.80M | 78.39M | -60.04M | -242.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -175.57M | -196.06M | -252.73M | -323.62M | -366.00M | |||
| Capital Expenditure | -266.00K | -312.00K | -8.35M | -19.04M | -64.24M | |||
| FREE CASH FLOW | -175.84M | -196.37M | -261.08M | -342.66M | -430.24M | |||
All data in USD